IGKC 抗体
Quick Overview for IGKC 抗体 (ABIN7267846)
抗原
适用
宿主
克隆类型
标记
应用范围
-
-
原理
- Human Ig Kappa Chain Rabbit mAb
-
交叉反应
- 人, 小鼠, 大鼠
-
产品特性
- Monoclonal Antibodies
-
纯化方法
- Affinity purification
-
免疫原
- A synthesized peptide derived from human Human Ig Kappa Chain
-
亚型
- IgG
-
-
anti-Immunoglobulin kappa Constant (IGKC) antibody
IGKC 适用: 人 IHC, StM, WB, FACS 宿主: 小鼠 Monoclonal KLC264 unconjugated
anti-Immunoglobulin kappa Constant (IGKC) (AA 1-236) antibodyIGKC 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 1F6 unconjugated
anti-Immunoglobulin kappa Constant (IGKC) antibodyIGKC 适用: 人 IHC, StM 宿主: 小鼠 Monoclonal rL1C1 unconjugated Recombinant Antibody
anti-Immunoglobulin kappa Constant (IGKC) (AA 1-234) antibodyIGKC 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
anti-Immunoglobulin kappa Constant (IGKC) (AA 1-107) antibodyIGKC 适用: 人 IHC, ELISA, IF 宿主: 兔 Polyclonal unconjugated
anti-Immunoglobulin kappa Constant (IGKC) (AA 1-236) antibodyIGKC 适用: 人 ELISA, IP 宿主: 小鼠 Monoclonal 2E7 unconjugated
anti-Immunoglobulin kappa Constant (IGKC) (AA 1-234) antibodyIGKC 适用: 人 WB, IHC (p) 宿主: 小鼠 Polyclonal unconjugated
anti-Immunoglobulin kappa Constant (IGKC) antibodyIGKC 适用: 人 IHC, StM 宿主: 兔 Monoclonal KLC2289R unconjugated Recombinant Antibody
anti-Immunoglobulin kappa Constant (IGKC) antibody (CF®488A)IGKC 适用: 人 IHC, StM, FACS 宿主: 小鼠 Monoclonal KLC709 CF®488A
-
-
应用备注
- WB,1:1000 - 1:5000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- IGKC (Immunoglobulin kappa Constant (IGKC))
-
别名
- IGKC
-
背景
- Constant region of immunoglobulin light chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen.,HCAK1, IGKCD, Km,Immunology & Inflammation,IGKC
-
分子量
- 26kDa
-
基因ID
- 3514
-
UniProt
- P01834
抗原
-
